N61.2 Granulomatous mastitis

Name of the Condition

• Granulomatous Mastitis
• ICD-10 Code: N61.2

Summary

Granulomatous mastitis is a rare inflammatory condition of the breast characterized by non-caseating granulomas, which are clusters of immune cells. It typically presents with a firm, tender mass or swelling, often accompanied by skin changes or nipple discharge. The condition is distinct from infectious mastitis and may mimic breast cancer, requiring careful evaluation to avoid misdiagnosis.

Causes

The exact cause of granulomatous mastitis is not fully understood, but it is thought to involve an abnormal immune response, possibly triggered by ductal obstruction, trauma, or autoimmune processes. Some cases have been associated with pregnancy, lactation, or underlying systemic conditions, though no single cause is universally accepted.

Risk Factors

• Pregnancy or lactation: Recent childbirth or breastfeeding may increase risk.
• Autoimmune conditions: History of systemic lupus erythematosus or other immune disorders.
• Ductal obstruction: Blockage of breast ducts, which can lead to inflammation.
• Trauma: Physical injury to the breast, including surgery or biopsy.

Symptoms

• Firm, palpable breast mass or swelling.
• Breast pain or tenderness.
• Skin changes, such as redness, thickening, or ulceration.
• Nipple discharge, which may be bloody or purulent.
• Fever or general malaise in some cases.

Diagnosis

Diagnosis is based on clinical evaluation, imaging (e.g., mammography or ultrasound), and tissue biopsy. The biopsy typically reveals non-caseating granulomas, which help differentiate granulomatous mastitis from infectious or malignant conditions. Additional tests may include blood work to rule out autoimmune or infectious causes.

Treatment Options

Treatment often involves a combination of anti-inflammatory medications, antibiotics (if infection is suspected), and, in some cases, corticosteroids to reduce inflammation. Surgical intervention may be necessary for persistent masses or complications. Close monitoring is essential to assess response to therapy.

Prognosis and Follow-Up

Most patients respond to treatment, though recurrence is possible. Follow-up care includes regular breast exams and imaging to monitor for changes. Long-term outcomes are generally favorable, but some individuals may experience chronic symptoms or require ongoing management.

Complications

Potential complications include abscess formation, chronic pain, or scarring. In rare cases, the condition may lead to breast deformity or persistent tissue damage. Early diagnosis and appropriate treatment help minimize these risks.

Lifestyle & Prevention

Maintaining breast health through regular self-exams and prompt evaluation of any new symptoms can aid in early detection. Avoiding trauma to the breast and managing underlying conditions (e.g., autoimmune disorders) may reduce risk. Breastfeeding practices should be optimized to prevent ductal obstruction.

When to Seek Professional Help

Seek medical attention if you notice a new breast mass, persistent pain, skin changes, or nipple discharge. Prompt evaluation is critical to rule out serious conditions like cancer or infection and to initiate appropriate treatment.

Tips for Medical Coders

When coding for granulomatous mastitis (N61.2), ensure documentation supports the diagnosis, including clinical findings, biopsy results, and exclusion of other causes (e.g., infection or malignancy). Note any associated factors like pregnancy or autoimmune history, as these may impact coding specificity. Verify that the code aligns with the provider’s clinical documentation to avoid miscoding.